2022

HAI welcomes new Foundation Board Chair

WTO institutionally unfit for purpose of delivering sustainable solutions

Introducing the TRIPS Flexibilities Navigator

EU rushing WTO members to adopt weak waiver text

HAI Statement on Tentative Agreement on TRIPS and COVID-19

Marking International Women’s Day 2022

HAI is Hiring!

Call for medical journals to support clinical trial transparency

2021

Looking to 2022 with Renewed Energy

Transparency: Bringing the Issue to Life

Working with the European Parliament

WHO Recommends Malaria Vaccine for Use

Over 9 million people living with type 1 diabetes

COVID-19: European Commission gives lacklustre response to legitimate civil society concerns

Clinical Trial Data and the Risk of Bias

Getting Hack to Reality

A Pandemic Response Lacking Moral Leadership

MPs and MEPs Call for TRIPS Waiver

Challenging the IP Protection Framework

Over 100 MEPs call for a TRIPS Waiver

Access to Medicines in Europe

Health Action International at 40 – A Word from Executive Director, Tim Reed

2020

There is no UHC without Universal Medicines Coverage

HAI’s Great Health Hack Delivers Great Ideas for Access to Meds

Pharmaceutical promotion: how does it impact rational use of medicine?

Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic

What do the next five years have in store for the European Medicines Agency?

Dutch institutions failing to register results of clinical trials

The significant impact of Health Technology Assessment discussions on national health systems

COVID-19 risks turning back the clock on years of essential development work